NCT07508891 Characterisation of phenotYpes in aCute Heart faiLure patiEnts
| NCT ID | NCT07508891 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Acute Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-03-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-03-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An observational cohort study to evaluate the benefit of functional parameters, radiomics and blood biomarkers to predict the outcome of patients with acute heart failure.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of acute heart failure, including all stages of cardiogenic shock, de novo heart failure as well as decompensated chronic heart failure. * Hospitalisation due to acute heart failure or new-onset acute heart failure during a hospitalisation de to a different cause. Out-patients with acute heart failure are not included. Exclusion Criteria: * Age \< 18 years * No written informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07508891 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07508891 currently recruiting?
Yes, NCT07508891 is actively recruiting participants. Contact the research team at b.schrage@uke.de for enrollment information.
Where is the NCT07508891 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT07508891 clinical trial?
NCT07508891 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.